Option Care Health, Inc. (NASDAQ:OPCH) Receives Average Recommendation of “Moderate Buy” from Brokerages

Shares of Option Care Health, Inc. (NASDAQ:OPCH) have been given a consensus rating of “Moderate Buy” by the fourteen brokerages that are presently covering the firm, MarketBeat.com reports. Seven research analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 1-year target price among brokers that have issued ratings on the stock in the last year is $29.9231.

A number of equities analysts have issued reports on OPCH shares. Stephens restated an “equal weight” rating and issued a $24.00 price objective (down from $30.00) on shares of Option Care Health in a research report on Friday, July 17th. Zacks Research upgraded shares of Option Care Health from a “strong sell” rating to a “hold” rating in a report on Monday, July 6th. Weiss Ratings raised Option Care Health from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $24.00 target price (down from $26.00) on shares of Option Care Health in a research note on Thursday, July 30th. Finally, UBS Group reaffirmed a “buy” rating on shares of Option Care Health in a research note on Tuesday, June 16th.

Institutional Investors Weigh In On Option Care Health

Several institutional investors and hedge funds have recently modified their holdings of OPCH. Norges Bank purchased a new stake in Option Care Health in the fourth quarter worth $61,787,000. Raiffeisen Bank International AG grew its position in Option Care Health by 92.3% in the 2nd quarter. Raiffeisen Bank International AG now owns 250,000 shares of the company’s stock worth $5,330,000 after purchasing an additional 120,000 shares during the period. Sumitomo Mitsui Trust Group Inc. purchased a new position in shares of Option Care Health in the 1st quarter worth $70,287,000. Gamco Investors INC. ET AL boosted its stake in shares of Option Care Health by 36.8% in the 4th quarter. Gamco Investors INC. ET AL now owns 369,002 shares of the company’s stock worth $11,756,000 after buying an additional 99,244 shares during the last quarter. Finally, Squarepoint Ops LLC grew its holdings in shares of Option Care Health by 234.1% in the second quarter. Squarepoint Ops LLC now owns 434,408 shares of the company’s stock worth $9,110,000 after acquiring an additional 304,376 shares during the period. 98.05% of the stock is owned by hedge funds and other institutional investors.

Option Care Health Price Performance

Shares of Option Care Health stock opened at $23.99 on Thursday. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.47 and a quick ratio of 0.98. Option Care Health has a one year low of $18.01 and a one year high of $36.80. The business’s 50 day simple moving average is $23.08 and its two-hundred day simple moving average is $24.30. The stock has a market capitalization of $3.59 billion, a P/E ratio of 18.04, a price-to-earnings-growth ratio of 1.36 and a beta of 0.61.

Option Care Health (NASDAQ:OPCH) last issued its earnings results on Wednesday, July 29th. The company reported $0.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.43 by $0.02. Option Care Health had a net margin of 3.68% and a return on equity of 18.74%. The firm had revenue of $1.44 billion for the quarter, compared to analysts’ expectations of $1.42 billion. During the same quarter last year, the business earned $0.41 earnings per share. The business’s revenue was up 1.9% on a year-over-year basis. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. Analysts forecast that Option Care Health will post 1.69 EPS for the current year.

About Option Care Health

Option Care Health, Inc is a provider of home and alternate-site infusion services in the United States. The company works with patients, physicians, hospitals, health plans and pharmaceutical manufacturers to deliver infusion therapy outside traditional hospital settings, including in patients’ homes, ambulatory infusion centers and other outpatient locations.

Its services include pharmacy and nursing support for intravenous and subcutaneous therapies, care coordination, patient education, clinical monitoring and reimbursement assistance.